Patents by Inventor Naohiro Araki

Naohiro Araki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180259512
    Abstract: The present invention provides a method and a kit for assaying a TSH receptor antibody, which are easy to manipulate and are safe. Specifically, the present invention provides a composition comprising a genetically modified cell forced to co-express a TSH receptor, a cyclic nucleotide responsive calcium channel, and a luminescent protein aequorin. Use of the composition enables the assay of a TSH receptor antibody contained in a sample.
    Type: Application
    Filed: April 16, 2018
    Publication date: September 13, 2018
    Applicant: Otsuka Pharmaceutical Co., Ltd.
    Inventor: Naohiro ARAKI
  • Patent number: 9316588
    Abstract: Provided are a procedurally simple and safe method and kit for measuring the concentration in a biological sample of a physiologically active substance which binds to a receptor that causes a change in intracellular cAMP concentration. By providing a composition including genetically-modified cells which show co-expression of a receptor that causes a change in intracellular cAMP concentration, a cyclic nucleotide-responsive calcium channel, and aequorin luminescent protein, it is possible to measure how much of a physiologically active substance which binds to said receptor is included in a biological sample.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: April 19, 2016
    Assignee: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Naohiro Araki, Mitsuru Iida, Kiyotaka Machida
  • Publication number: 20140072985
    Abstract: The present invention provides a method and a kit for assaying a TSH receptor antibody, which are easy to manipulate and are safe. Specifically, the present invention provides a composition comprising a genetically modified cell forced to co-express a TSH receptor, a cyclic nucleotide responsive calcium channel, and a luminescent protein aequorin. Use of the composition enables the assay of a TSH receptor antibody contained in a sample.
    Type: Application
    Filed: August 13, 2013
    Publication date: March 13, 2014
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventor: Naohiro ARAKI
  • Publication number: 20130280734
    Abstract: Provided are a procedurally simple and safe method and kit for measuring the concentration in a biological sample of a physiologically active substance which binds to a receptor that causes a change in intracellular cAMP concentration. By providing a composition including genetically-modified cells which show co-expression of a receptor that causes a change in intracellular cAMP concentration, a cyclic nucleotide-responsive calcium channel, and aequorin luminescent protein, it is possible to measure how much of a physiologically active substance which binds to said receptor is included in a biological sample.
    Type: Application
    Filed: December 22, 2011
    Publication date: October 24, 2013
    Inventors: Naohiro Araki, Mitsuru Iida, Kiyotaka Machida
  • Publication number: 20120149036
    Abstract: The present invention provides a method and a kit for assaying a TSH receptor antibody, which are easy to manipulate and are safe. Specifically, the present invention provides a composition comprising a genetically modified cell forced to co-express a TSH receptor, a cyclic nucleotide responsive calcium channel, and a luminescent protein aequorin. Use of the composition enables the assay of a TSH receptor antibody contained in a sample.
    Type: Application
    Filed: June 24, 2010
    Publication date: June 14, 2012
    Inventor: Naohiro Araki
  • Publication number: 20100159449
    Abstract: To measure a receptor-mediated increase in intracellular calcium concentration, use is made of a calcium-responding luminescent protein localized in the cytoplasm or mitochondria and a reporter gene having a promoter responding to the second messenger in cells and Renilla-origin luciferase attached to the downstream thereof. By using a coelenterazine derivative, which can exist in the cells in a stable state over a long time, as the substrate of these proteins, a transient increase in the intracellular calcium concentration observed within several seconds is measured by using the calcium-responding luminescent protein. Subsequently, the cells are allowed to survive and cultured for several hours as such without adding a fresh substrate. During this period, an increase/decrease in the gene expression is continuously monitored by the reporter assay method and it is measured and evaluated, if necessary, whether or not the inhibition of the activity is caused by cytotoxicity.
    Type: Application
    Filed: May 28, 2007
    Publication date: June 24, 2010
    Applicant: NOACELL SCIENCE CO., LTD.
    Inventors: Mitsuru Iida, Naohiro Araki, Hisatoshi Yabushita, Yoshikazu Suzuki